Engagetherapeutics
1 known investors
UCB is a global biopharmaceutical company focused on creating treatments for people living with neurological and autoimmune conditions. The company develops medicines and patient support services to improve outcomes for patients with diseases such as myasthenia gravis and axSpA.
BiotechHealthtech